From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.
Riethmüller
G
G
Institut für Immunologie, Universität München, Germany.
Rieber
E P
EP
Kiefersauer
S
S
Prinz
J
J
van der Lubbe
P
P
Meiser
B
B
Breedveld
F
F
Eisenburg
J
J
Krüger
K
K
Deusch
K
K
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000628:therapy*; D015704:CD4 Antigens / Q000276:immunology*; D006801:Humans; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015704:CD4 Antigens; D011993:Recombinant Fusion Proteins